USING CANNABIS IN THE TREATMENT OF MYASTHENIA GRAVIS

Dr. Frankel shares his insight on treating Myasthenia Gravis with cannabis and results from recent cases at GreenBridge Medical using CBD, THC & THC-Acid.

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

WHILE CONSIDERING CHEMOTHERAPY…

Dr Frankel talks about chemotherapy, it's issues/side effects, and how cannabis can alleviate some of those issues, prevent others, and help enhance the effectiveness of the chemo. He uses a few patient cases to illustrate his approach.

DR MERCOLA INTERVIEWS DR ALLAN FRANKEL

Dr. Mercola interviews Dr. Frankel on many areas of medical cannabis. Topics discussed range from THCV, home growing, dabbing issues, Cannabis Hyperemesis, Myasthenia Gravis and the future of medical cannabis.

EPIDIOLEX VERSUS WHOLE PLANT CANNABIS CBD

Dr Frankel has long been a proponent of using whole plant, cannabis derived CBD products and a recent case in which a patient had less effective results when switching to a prescribed CBD isolate further cemented his stance on what works best for patients

CAN CANNABIS CAUSE ARTERIAL DAMAGE?

Dr Frankel gives his thoughts and counterpoints on the potential issue of cannabis causing arterial damage after some articles were recently circulating about this subject.

POTENTIAL BENEFITS OF THC-V

Dr Frankel talks about his experience using THC-V for different medical issues, the initial results he has seen and his hope for more research to be done.